Back to Journals » International Journal of Nanomedicine » Volume 4

Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers

Authors Dhruba J Bharali, Marianne Khalil, Mujgan Gurbuz, Tessa M Simone, Shaker A Mousa

Published 20 January 2009 Volume 2009:4 Pages 1—7

DOI https://doi.org/10.2147/IJN.S4241

Review by Single-blind

Peer reviewer comments 4

Dhruba J Bharali, Marianne Khalil, Mujgan Gurbuz, Tessa M Simone, Shaker A Mousa

Pharmaceutical Research Institute at Albany College of Pharmacy, Rensselaer, NY, USA

Abstract: The emergence of nanotechnology has had a profound effect on many areas of healthcare and scientific research. Having grown exponentially, the focus of nanotechnology has been on engineering diversified novel applications that even go beyond therapeutic activity; nanotechnology also offers the ability to detect diseases, such as cancer, much earlier than ever imaginable. Often, patients diagnosed with breast, lung, colon, prostate, and ovarian cancer have hidden or overt metastatic colonies. With the advent of diagnostic nanotechnology, these numbers are expected to greatly diminish. This review provides a brief description of nanoparticle (liposome, quantum dot, and dendrimer)-mediated cancer therapy in the last decade with an emphasis on the development and use of dendrimers in cancer therapeutics.

Keywords: nanoparticles, dendrimer, quantum dots, liposome

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other articles by this author:

Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder

Christine Brady, Shaymaa S Mousa, Shaker A Mousa

Drug, Healthcare and Patient Safety 2009, 1:9-15

Published Date: 3 February 2009

Preferred drug lists: Potential impact on healthcare economics

Kimberly Ovsag, Sabrina Hydery, Shaker A Mousa

Vascular Health and Risk Management 2008, 4:403-413

Published Date: 11 April 2008

Readers of this article also read:

Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovo

Grodzik M, Sawosz E, Wierzbicki M, Orlowski P, Hotowy A, Niemiec T, Szmidt M, Mitura K, Chwalibog A

International Journal of Nanomedicine 2011, 6:3041-3048

Published Date: 25 November 2011

Erratum

Iancu C, Mocan L

International Journal of Nanomedicine 2011, 6:2543-2544

Published Date: 21 October 2011

Molecular network topology and reliability for multipurpose diagnosis

Jalil MA, Moongfangklang N, Innate K, Mitatha S, Ali J, Yupapin PP

International Journal of Nanomedicine 2011, 6:2385-2392

Published Date: 19 October 2011

Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm

Xie S, Pan B, Shi B, Zhang Z, Zhang X, Wang M, Zhou W

International Journal of Nanomedicine 2011, 6:2367-2374

Published Date: 18 October 2011

Microencapsulation of nanoemulsions: novel Trojan particles for bioactive lipid molecule delivery

Li X, Anton N, Ta TMC, Zhao M, Messaddeq N, Vandamme TF

International Journal of Nanomedicine 2011, 6:1313-1325

Published Date: 24 June 2011

Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes

Garro AG, Beltramo DM, Alasino RV, Leonhard V, Heredia V, Bianco ID

International Journal of Nanomedicine 2011, 6:1193-1200

Published Date: 13 June 2011

Eye disorders in patients with multiple sclerosis: natural history and management

Jennifer Graves, Laura J Balcer

Clinical Ophthalmology 2010, 4:1409-1422

Published Date: 6 December 2010

Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography

Grant D Aaker, Jane S Myung, Joshua R Ehrlich, et all

Clinical Ophthalmology 2010, 4:1427-1432

Published Date: 6 December 2010